Efficacy and Safety of Oteseconazole in Recurrent Vulvovaginal Candidiasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Oteseconazole in Recurrent Vulvovaginal Candidiasis

Published:2022-07-26 Issue:8 Volume:1 Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Sobel Jack D.¹,Donders Gilbert²,Degenhardt Thorsten³,Person Karen³,Curelop Stacey³,Ghannoum Mahmoud⁴,Brand Stephen R.³

Affiliation:

1. Department of Internal Medicine, School of Medicine, Wayne State University, Detroit

2. Department of Obstetrics and Gynecology, Regional Hospital H Hart Tienen, Femicare Research Tienen, University Hospital Antwerp, Tienen, Belgium

3. Mycovia Pharmaceuticals, Inc., Durham, NC

4. Department of Pathology, Case Western Reserve University School of Medicine, Cleveland

Publisher

Massachusetts Medical Society

Reference27 articles.

1. Recurrent vulvovaginal candidiasis

2. Global burden of recurrent vulvovaginal candidiasis: a systematic review

3. Prevalence of Recurrent Vulvovaginal Candidiasis in 5 European Countries and the United States

4. Recurrent vulvovaginal candidiasis

5. Causes of Chronic Vaginitis

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Therapies and Treatments in Women’s Health;Medical Clinics of North America;2024-09

2. Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease;Clinical Microbiology Reviews;2024-06-13

3. Pipeline of Novel Antifungals for Invasive Fungal Disease in Transplant Recipients: A Pediatric Perspective;Journal of the Pediatric Infectious Diseases Society;2024-02-01

4. Oteseconazole versus fluconazole for the treatment of severe vulvovaginal candidiasis: a multicenter, randomized, double-blinded, phase 3 trial;Antimicrobial Agents and Chemotherapy;2024-01-10

5. TO MARKET, TO MARKET–2022: SMALL MOLECULES;Medicinal Chemistry Reviews;2023-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3